1. Home
  2. CRVS vs NOA Comparison

CRVS vs NOA Comparison

Compare CRVS & NOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRVS
  • NOA
  • Stock Information
  • Founded
  • CRVS 2014
  • NOA 1953
  • Country
  • CRVS United States
  • NOA Canada
  • Employees
  • CRVS N/A
  • NOA N/A
  • Industry
  • CRVS Biotechnology: Pharmaceutical Preparations
  • NOA Meat/Poultry/Fish
  • Sector
  • CRVS Health Care
  • NOA Consumer Staples
  • Exchange
  • CRVS Nasdaq
  • NOA Nasdaq
  • Market Cap
  • CRVS 459.0M
  • NOA 478.5M
  • IPO Year
  • CRVS 2016
  • NOA 2006
  • Fundamental
  • Price
  • CRVS $7.00
  • NOA $14.50
  • Analyst Decision
  • CRVS Strong Buy
  • NOA
  • Analyst Count
  • CRVS 3
  • NOA 0
  • Target Price
  • CRVS $13.00
  • NOA N/A
  • AVG Volume (30 Days)
  • CRVS 789.4K
  • NOA 111.4K
  • Earning Date
  • CRVS 11-11-2025
  • NOA 10-29-2025
  • Dividend Yield
  • CRVS N/A
  • NOA 2.37%
  • EPS Growth
  • CRVS N/A
  • NOA N/A
  • EPS
  • CRVS N/A
  • NOA 0.87
  • Revenue
  • CRVS N/A
  • NOA $919,386,154.00
  • Revenue This Year
  • CRVS N/A
  • NOA $16.14
  • Revenue Next Year
  • CRVS N/A
  • NOA $3.55
  • P/E Ratio
  • CRVS N/A
  • NOA $16.59
  • Revenue Growth
  • CRVS N/A
  • NOA 14.15
  • 52 Week Low
  • CRVS $2.54
  • NOA $12.12
  • 52 Week High
  • CRVS $10.00
  • NOA $22.08
  • Technical
  • Relative Strength Index (RSI)
  • CRVS 58.81
  • NOA 53.38
  • Support Level
  • CRVS $6.65
  • NOA $13.66
  • Resistance Level
  • CRVS $7.39
  • NOA $15.13
  • Average True Range (ATR)
  • CRVS 0.42
  • NOA 0.39
  • MACD
  • CRVS -0.04
  • NOA 0.14
  • Stochastic Oscillator
  • CRVS 55.47
  • NOA 61.36

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

About NOA North American Construction Group Ltd. (no par)

North American Construction Group Ltd is Canada's heavy civil construction and mining contractor provider. The company has provided services to oil, natural gas, and resource companies. The Company provides a wide range of mining and heavy civil construction services to customer in the resource development and industrial construction sectors within Canada, the United States, and Australia. The Company's reportable segments are Heavy Equipment Canada, Heavy Equipment Australia, and Other. Heavy Equipment Canada and Heavy Equipment Australia include all of aspects of the mining and heavy civil construction services provided within those geographic areas. Other includes mine management contract work in the United States, its external maintenance and rebuild programs.

Share on Social Networks: